Related Experiment Video
Updated: Jun 30, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology
Kathleen Beusterien1, Oliver Will2, Emuella Flood3
1Real World Evidence, Oracle, Kansas City, MO, USA. kathleen.beusterien@oracle.com.
Patients prioritize avoiding serious adverse events and prefer flexible cancer treatment pathways. This study developed a new method to assess patient preferences across complex treatment sequences.
Area of Science:
- Oncology
- Health Services Research
- Decision Science
Background:
- Cancer patients often undergo sequential treatments with varying side effects.
- Treatment pathways can be fixed or flexible, allowing for adjustments based on outcomes.
- A methodology is needed to estimate patient preferences for entire treatment sequences.
Purpose of the Study:
- To develop a novel methodology for estimating patient preferences across complex, sequential cancer treatment pathways.
- To assess patient preferences for key attributes of early breast cancer treatment pathways.
Main Methods:
- An online discrete choice experiment was conducted with early breast cancer patients.
- Hierarchical Bayesian modeling calculated attribute-level preference weights.
- Pathway preferences were estimated by summing time-adjusted weights for efficacy, pathway flexibility, duration, administration, and adverse events.
Main Results:
- Serious adverse event risk was the most significant factor in treatment pathway preferences.
- Patients showed a strong preference for flexible over fixed treatment pathways.
- Increased efficacy and decreased pathway duration also positively influenced preferences.
Conclusions:
- A new methodology enables comprehensive patient preference assessment for sequential cancer treatments.
- This approach facilitates the comparison of complex treatment pathways based on patient values.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...